Market research
SELB Selecta Biosciences Inc
US USD Not available
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the SELB discussion.
5 years, 4 months ago
Selecta Biosciences, Inc is currently in a long term uptrend where the price is trading 14.0% above its 200 day moving average.
From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 27.8.
Selecta Biosciences, Inc's total revenue rose by 79.6% to $12M since the same quarter in the previous year.
Its net income has dropped by 3.7% to $-15M since the same quarter in the previous year.
Finally, its free cash flow grew by 42.4% to $-7M since the same quarter in the previous year.
Based on the above factors, Selecta Biosciences, Inc gets an overall score of 4/5.